Methyl 2-(1,4-diazepan-1-yl)-2-methylpropanoate hydrochloride, 1g

Methyl 3-methoxy-2-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 98%, 5g

7-Bromo-6-fluoroquinazoline-2,4(1H,3H)-dione, 97%, 100mg

6-Isopropylisoquinoline, 97%, 25g

2'-C-Methylcytidine, 95.0%, 1g

2-Amino-4-bromobenzo[b]thiophene-3-carbonitrile, 98%, 250mg

Piperidine, PEPTIPURE®, min. 99.5%, for peptide synthesis, 1L, glass packaging

4-Hydroxythieno[3,2-c]pyridine, 97.0%, 10g

N-(4-chlorobenzyl)ethanamine, 95.0%, 100g

Ethyl 2-(3-bromo-2-methylphenyl)acetate, 97.0%, 250mg

(R)-1-Methylpiperidine-2-carboxylic acid hydrochloride, 98.0%, 5g

6,6'-Dimethyl 5,5'-dibromo-2H,2'H,3H,3'H-[1,1'-biindole]-6,6'-dicarboxylate, 97%, 500mg

3-bromopentane, 90.0%, 25g